从TC2N中鉴定出一种新的受HLA-A*0201限制的细胞毒性T淋巴细胞表位
Zhao Yang1, Hongchuan Zhang2, Xiaohui Xia1
11Department of Neurology, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.
European journal of microbiology & immunology
|February 15, 2024
概括
研究人员从TC2N瘤抗原RLYGSVCDL中鉴定出一种新型,可以有效触发细胞毒性T淋巴细胞 (CTL) 对质母细胞瘤的反应. 这一发现为基于的免疫疗法在脑癌治疗中提供了一个有希望的新途径.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 恶性瘤免疫疗法依赖于从瘤相关抗原中识别细胞毒性T淋巴细胞 (CTL) 表位.
- 最近发现的人类质母细胞瘤抗原TC2N是瘤特异性免疫治疗的潜在标.
- HLA-A*0201是一种常见的基因相容性分子,使其成为特定人群免疫治疗策略的相关目标.
研究的目的:
- 为了识别和表征来自TC2N瘤抗原的HLA-A*0201受限制的CTL表位.
- 评估针对质母细胞瘤的已识别的TC2N衍生的免疫治疗潜力.
主要方法:
- 来自TC2N的抗原的生物信息预测.
- 对HLA-A*0201.1.0的最高得分的合成和结合亲和度评估.
- 在体外和体外刺激T细胞对预测的反应.
- 评估由引起的CTLs调节的IFN-γ释放和瘤细胞溶解.
主要成果:
- 配列RLYGSVCDL的TC2N (152-160) 显示出对HLA-A*0201.1具有显著的结合亲和力.
- 在体外和体内研究证实TC2N (152-160) 诱导特异性CTLs.
- 这些CTL能够释放IFN-γ并溶解U251质母细胞瘤细胞.
结论:
- TC2N (152-160) (RLYGSVCDL) 是一种新的HLA-A2.1受限制的CTL表位.
- 这种表位可以诱导TC2N特定的CTLs,证明其对质母细胞瘤免疫疗法的潜力.
- 已识别的表位RLYGSVCDL可能是开发基于的,针对GBM的癌症特异性免疫疗法的宝贵组成部分.
更多相关视频
相关概念视频
T Cell Activation and Clonal Selection
732
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
732
Cytotoxic T Cells-mediated Immune Response
910
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
910
Antigens Involved in Adaptive Immunity
492
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
492


